Key Record Dates
| ClinicalTrials.gov Identifier: | NCT05894239 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer |
| First Submitted : | May 24, 2023 |
| First Submitted that Met QC Criteria : | June 7, 2023 |
| First Posted : | June 8, 2023 |
| Last Update Submitted that Met QC Criteria : | May 16, 2024 |
| Last Update Posted : | May 17, 2024 |